Your browser doesn't support javascript.
loading
Loss of tubulin deglutamylase CCP1 causes infantile-onset neurodegeneration.
Shashi, Vandana; Magiera, Maria M; Klein, Dennis; Zaki, Maha; Schoch, Kelly; Rudnik-Schöneborn, Sabine; Norman, Andrew; Lopes Abath Neto, Osorio; Dusl, Marina; Yuan, Xidi; Bartesaghi, Luca; De Marco, Patrizia; Alfares, Ahmed A; Marom, Ronit; Arold, Stefan T; Guzmán-Vega, Francisco J; Pena, Loren Dm; Smith, Edward C; Steinlin, Maja; Babiker, Mohamed Oe; Mohassel, Payam; Foley, A Reghan; Donkervoort, Sandra; Kaur, Rupleen; Ghosh, Partha S; Stanley, Valentina; Musaev, Damir; Nava, Caroline; Mignot, Cyril; Keren, Boris; Scala, Marcello; Tassano, Elisa; Picco, Paolo; Doneda, Paola; Fiorillo, Chiara; Issa, Mahmoud Y; Alassiri, Ali; Alahmad, Ahmed; Gerard, Amanda; Liu, Pengfei; Yang, Yaping; Ertl-Wagner, Birgit; Kranz, Peter G; Wentzensen, Ingrid M; Stucka, Rolf; Stong, Nicholas; Allen, Andrew S; Goldstein, David B; Schoser, Benedikt; Rösler, Kai M.
Afiliación
  • Shashi V; Division of Medical Genetics, Department of Pediatrics, Duke University Medical Center, Durham, NC, USA vandana.shashi@duke.edu carsten.janke@curie.fr jan.senderek@med.uni-muenchen.de.
  • Magiera MM; Institut Curie, CNRS UMR3348, PSL Research University, Orsay, France.
  • Klein D; CNRS UMR3348, Université Paris Sud, Université Paris-Saclay, Orsay, France.
  • Zaki M; Department of Neurology, Developmental Neurobiology, University Hospital Würzburg, Würzburg, Germany.
  • Schoch K; Clinical Genetics Department, Human Genetics and Genome Research Division, National Research Centre, Cairo, Egypt.
  • Rudnik-Schöneborn S; Division of Medical Genetics, Department of Pediatrics, Duke University Medical Center, Durham, NC, USA.
  • Norman A; Division of Human Genetics, Medical University Innsbruck, Innsbruck, Austria.
  • Lopes Abath Neto O; Department of Clinical Genetics, St. Michael's Hospital, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
  • Dusl M; Neuromuscular and Neurogenetic Disorders of Childhood Section, Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD, USA.
  • Yuan X; Friedrich Baur Institute at the Department of Neurology, Friedrich Baur Institute, University Hospital, LMU Munich, Munich, Germany.
  • Bartesaghi L; Department of Neurology, Developmental Neurobiology, University Hospital Würzburg, Würzburg, Germany.
  • De Marco P; Department of Neuroscience and Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Alfares AA; IRCCS Istituto Giannina Gaslini, Genova, Italy.
  • Marom R; Department of Pediatrics, College of Medicine, Qassim University, Qassim, Saudi Arabia.
  • Arold ST; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
  • Guzmán-Vega FJ; Texas Children's Hospital, Houston, TX, USA.
  • Pena LD; Division of Biological and Environmental Sciences and Engineering (BESE), Computational Bioscience Research Center (CBRC), King Abdullah University of Science and Technology (KAUST), Thuwal, Saudi Arabia.
  • Smith EC; Division of Biological and Environmental Sciences and Engineering (BESE), Computational Bioscience Research Center (CBRC), King Abdullah University of Science and Technology (KAUST), Thuwal, Saudi Arabia.
  • Steinlin M; Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  • Babiker MO; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
  • Mohassel P; Division of Neurology, Department of Pediatrics, Duke University Medical Center, Durham, NC, USA.
  • Foley AR; Division of Neuropaediatrics, Development and Rehabilitation, University Children's Hospital, Inselspital, University of Bern, Bern, Switzerland.
  • Donkervoort S; Neurosciences Centre, Al Jalila Children's Hospital, Dubai, UAE.
  • Kaur R; Neuromuscular and Neurogenetic Disorders of Childhood Section, Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD, USA.
  • Ghosh PS; Neuromuscular and Neurogenetic Disorders of Childhood Section, Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD, USA.
  • Stanley V; Neuromuscular and Neurogenetic Disorders of Childhood Section, Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD, USA.
  • Musaev D; Neuromuscular and Neurogenetic Disorders of Childhood Section, Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD, USA.
  • Nava C; Department of Neurology, Boston Children's Hospital, Boston, MA, USA.
  • Mignot C; Laboratory for Pediatric Brain Disease, Howard Hughes Medical Institute, University of California, San Diego, CA, USA.
  • Keren B; Laboratory for Pediatric Brain Disease, Howard Hughes Medical Institute, University of California, San Diego, CA, USA.
  • Scala M; Department of Genetics, Assistance Publique des Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Paris, France.
  • Tassano E; Institut du Cerveau et de la Moelle épinière, Sorbonne Universités, Inserm U1127, CNRS, UMR 7225, UPMC Univ Paris 06, Paris, France.
  • Picco P; Department of Genetics, Assistance Publique des Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Paris, France.
  • Doneda P; Institut du Cerveau et de la Moelle épinière, Sorbonne Universités, Inserm U1127, CNRS, UMR 7225, UPMC Univ Paris 06, Paris, France.
  • Fiorillo C; Department of Genetics, Assistance Publique des Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Paris, France.
  • Issa MY; Institut du Cerveau et de la Moelle épinière, Sorbonne Universités, Inserm U1127, CNRS, UMR 7225, UPMC Univ Paris 06, Paris, France.
  • Alassiri A; IRCCS Istituto Giannina Gaslini, Genova, Italy.
  • Alahmad A; IRCCS Istituto Giannina Gaslini, Genova, Italy.
  • Gerard A; IRCCS Istituto Giannina Gaslini, Genova, Italy.
  • Liu P; Grande Ospedale Metropolitano Niguarda, Milano, Italy.
  • Yang Y; IRCCS Istituto Giannina Gaslini, Genova, Italy.
  • Ertl-Wagner B; Università degli Studi di Genova, Genova, Italy.
  • Kranz PG; Clinical Genetics Department, Human Genetics and Genome Research Division, National Research Centre, Cairo, Egypt.
  • Wentzensen IM; Department of Pathology and Laboratory Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • Stucka R; Department of Pathology and Laboratory Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • Stong N; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
  • Allen AS; Texas Children's Hospital, Houston, TX, USA.
  • Goldstein DB; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
  • Schoser B; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
  • Rösler KM; Baylor Genetics, Houston, TX, USA.
EMBO J ; 37(23)2018 12 03.
Article en En | MEDLINE | ID: mdl-30420557
ABSTRACT
A set of glutamylases and deglutamylases controls levels of tubulin polyglutamylation, a prominent post-translational modification of neuronal microtubules. Defective tubulin polyglutamylation was first linked to neurodegeneration in the Purkinje cell degeneration (pcd) mouse, which lacks deglutamylase CCP1, displays massive cerebellar atrophy, and accumulates abnormally glutamylated tubulin in degenerating neurons. We found biallelic rare and damaging variants in the gene encoding CCP1 in 13 individuals with infantile-onset neurodegeneration and confirmed the absence of functional CCP1 along with dysregulated tubulin polyglutamylation. The human disease mainly affected the cerebellum, spinal motor neurons, and peripheral nerves. We also demonstrate previously unrecognized peripheral nerve and spinal motor neuron degeneration in pcd mice, which thus recapitulated key features of the human disease. Our findings link human neurodegeneration to tubulin polyglutamylation, entailing this post-translational modification as a potential target for drug development for neurodegenerative disorders.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Nervios Periféricos / Células de Purkinje / Columna Vertebral / Carboxipeptidasas / Degeneraciones Espinocerebelosas / Cerebelo / Neuronas Motoras Tipo de estudio: Etiology_studies Límite: Female / Humans / Male Idioma: En Revista: EMBO J Año: 2018 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Nervios Periféricos / Células de Purkinje / Columna Vertebral / Carboxipeptidasas / Degeneraciones Espinocerebelosas / Cerebelo / Neuronas Motoras Tipo de estudio: Etiology_studies Límite: Female / Humans / Male Idioma: En Revista: EMBO J Año: 2018 Tipo del documento: Article